I am an oral health researcher with primary interests in dental health services research and oral epidemiology, oral treatment needs among patients at high risk of disease or subject to health and social disparities, and analysis of professional practices – including how dental professionals make therapeutic decisions. My current research agenda includes: to expand studies in oral epidemiology and dental health services, research for all types of populations groups (both in North America and in less developed countries), with special attention to the identification, characterization, evaluation, and contrasts of disease manifestations and associated risk factors. To learn more or view my publications, please visit the following sites: ResearchGate Profile (Publications) - https://www.researchgate.net/profile/Gerardo_Maupome IU School of Dentistry Professor Profile - https://www.dentistry.iu.edu/index.php/faculty/maupome-gerardo/ Google Scholar Profile - https://scholar.google.com/citations?user=qXm2uJ0AAAAJ&hl=en
You have not backed any projects.
Lets change that!
Discover Projects
No project created yet.
Lets change that!
Discover Projects
No comments on any project yet.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No project reviewed yet.
Lets change that!
Discover Projects
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.